ASELAGE STEVE has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 6820 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on June 12, 2024.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ASELAGE STEVE | Director | A | Common Stock | 6820 | $0.00 | 72,659.0000 | 192,198,000 | 10.36% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ASELAGE STEVE | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| May 24, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ASELAGE STEVE | Director | P | Common Stock | 2500 | $6.40 | 65,839.0000 | 192,198,000 | 3.95% | 0.00% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ASELAGE STEVE | Director | A | Common Stock | 16745 | $0.00 | 63,339.0000 | 185,908,000 | 35.94% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | ASELAGE STEVE | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |